Although polymorphisms in TLR4 gene affecting LPS signaling have been described in patients with chronic inflammatory bowel diseases (IBD), their pathophysiological relevance in neuroimmune cross talk is still unclear (Cario, 2010). Here, TLR4 is linked to irritable bowel syndrome.